PMC5742556

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher mental component scores on the SF-36 over 6 months compared to those receiving medications alone, with an 8.2-

Effect: improvement; 8.2 point advantage (MCS); CI: 95% CI 4.2-12.2

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4

Elderly MDD patients receiving continuation ECT plus medications had significantly higher physical component scores on the SF-36 over 6 months compared to those receiving medications alone, with a 7-p

Effect: improvement; 7 point advantage (PCS); CI: 95% CI 3.5-10.4